(Q51035073)

27 March 2018

title

IVIg attenuates TLR-9 activation in B cells from SLE patients. (English)

1 reference

27 March 2018

0 references

8

Yehuda Shoenfeld

1 reference

27 March 2018

9

Elias Toubi

1 reference

27 March 2018

Aharon Kessel

1

1 reference

27 March 2018

Regina Peri

2

1 reference

27 March 2018

Tharwat Haj

3

1 reference

27 March 2018

Ayelet Snir

4

1 reference

27 March 2018

Gleb Slobodin

5

1 reference

27 March 2018

Edmond Sabo

6

1 reference

27 March 2018

Itzhak Rosner

7

1 reference

27 March 2018

publication date

5 October 2010

1 reference

27 March 2018

Journal of Clinical Immunology

published in

1 reference

27 March 2018

volume

31

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

30-38

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1007/s10875-010-9469-3

exact match

0 references

cites work

From T to B and back again: positive feedback in systemic autoimmune disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Maintenance of serological memory by polyclonal activation of human memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Toll-like receptors in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Interleukin 6 promotes murine lupus in NZB/NZW F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Fc gamma RIIB as a potential molecular target for intravenous gamma globulin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Spontaneous internalization of IVIg in activated B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-010-9469-3

Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood

21 January 2018

1 reference

12 December 2020

Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells

1 reference

12 December 2020

Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

1 reference

12 December 2020

Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement

1 reference

12 December 2020

The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin

1 reference

12 December 2020

Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.

1 reference

12 December 2020

Half-life and clearance of pH 6.8 and pH 4.25 immunoglobulin G intravenous preparations in patients with primary disorders of humoral immunity

1 reference

12 December 2020

Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process

1 reference

12 December 2020

Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)

1 reference

12 December 2020

High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study

1 reference

12 December 2020

Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus

1 reference

12 December 2020

Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins

1 reference

12 December 2020

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

1 reference

12 December 2020

Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus

1 reference

12 December 2020

Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression

1 reference

12 December 2020

Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.

1 reference

12 December 2020

Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

1 reference

12 December 2020

Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus

1 reference

12 December 2020

Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells

1 reference

12 December 2020

Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins

1 reference

12 December 2020

In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity

1 reference

12 December 2020

10.1007/S10875-010-9469-3

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

20922561

1 reference

27 March 2018